Cognizant Launches AI-Powered Patient Hub to Cut Therapy Waits from 30 Days to Under Seven
November 18, 2026
Cognizant estimates the approach could cut the typical prescription-to-therapy timeline from about 30 days to fewer than seven, based on its analysis of current workflows and case volumes.
Cognizant has introduced Patient Hub Operations, an offering that pairs AI agents with healthcare-experienced specialists to streamline patient access and reduce administrative delays between prescription and therapy.
Available now, the service starts insurance coverage checks, prior authorization, and financial-assistance work in parallel from intake.
The launch includes five AI agents for patient inquiries, routing, translation, human handoff, and call summarization; they handle conversations and routine administrative tasks using each program’s prescribing information, standard operating procedures, and payer rules.
Patient Hub Operations connects with clients’ existing CRM, contact center, and workflow systems, while Cognizant specialists review and approve AI-prepared actions involving regulatory decisions.
Built with technical support from NVIDIA, the service runs on NVIDIA accelerated computing and uses NVIDIA NIM speech microservices, NeMo Guardrails, and Cognizant-customized NVIDIA Nemotron language and speech models; clients can host it in their own cloud and retain control of their data and model customizations.
The system is designed for HIPAA-aligned handling of patient information and connects with Cognizant AI Nexus for governance.
When programs need clinical expertise, specialists can draw on Cognizant’s life sciences clinical staff, which the company says includes more than 5,000 pharmacists and doctors and more than 2,000 nurses.
The offering is available immediately to life sciences companies that operate patient support programs.
Summary based on 9 sources



